0 items USD 0.00Search
Your search for "asia market information development co hepatitis drugs markets china" gave back 1549396 results.
Market Analysis and Insights: Global Hepatitis B Virus Treatment Market The global Hepatitis B Virus Treatment market is projected to grow from US$...
Catalog:
MRRPB5
September 2023
Price: USD 4,900.00
Hepatitis therapeutics are a serial treatment methods targeting on Hepatitis A, Hepatitis B,Hepatitis C and Alcoholic Hepatitis. According to our...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Antineoplastic interferons are a type of drug class that belong to the large family of cytokines and are manufactured through the process of...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Antineoplastic interferons are a type of drug class that belong to the large family of cytokines and are manufactured through the process of...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Glucokinase - Pipeline Review, H1 2020 Summary Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) pipeline Target constitutes close to...
Catalog:
Global Markets Direct
May 2020
Price: USD 3,500.00
Nephrotic Syndrome (Genitourinary Disorders) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare...
Catalog:
Global Markets Direct
September 2021
Price: USD 2,000.00
The global Liver Fibrosis Drug market size was valued at USD 12290 million in 2023 and is forecast to a readjusted size of USD 10950 million by 2030...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Probable ATP Dependent RNA Helicase DDX58 - Pipeline Review, H2 2019 Summary According to the recently published report 'Probable ATP Dependent...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Nephrotic Syndrome - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
November 2020
Price: USD 2,000.00
Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022...
Catalog:
Global Markets Direct
September 2022
Price: USD 3,500.00
Tetanus - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tetanus -...
Catalog:
Global Markets Direct
March 2020
Price: USD 2,000.00
Hepatitis C Virus Envelope Protein E2 Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Hepatitis...
Catalog:
Global Markets Direct
October 2022
Price: USD 3,500.00
Haemophilus influenzae Type B Infections - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
October 2020
Price: USD 2,000.00
Hepatitis C Virus Envelope Protein E2 - Drugs in Development, 2021 Summary Hepatitis C Virus Envelope Protein E2 pipeline Target constitutes close to...
Catalog:
Global Markets Direct
October 2021
Price: USD 3,500.00
Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Pipeline Review, H2 2018 Summary Glucokinase (Hexokinase D or Hexokinase 4 or GCK...
Catalog:
Global Markets Direct
October 2018
Price: USD 3,500.00
